Proteins and Peptides
28 April 2016
European Commission Approves Surgical Patch TachoSil® (human thrombin/human fibrogen) for Use in Neurological Surgery28 April 2016
Semaglutide significantly reduces the risk of major adverse cardiovascular events in the SUSTAIN 6 trial26 April 2016
Alizé Pharma reports positive results from its Phase II clinical trial of AZP-531 in Prader-Willi Syndrome5 April 2016
Oramed Completes Phase IIb Oral Insulin Study4 April 2016
Motus Completes Enrollment of Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis4 April 2016
Baxalta Expands Global Reach of ADYNOVATE for Hemophilia A Patients with Approval in Japan4 April 2016
Semaglutide Demonstrated Superior Improvements in Glycemic Control vs Placebo in Adults with Type 2 Diabetes1 April 2016
Akari Therapeutics Announces Positive Preliminary Results from First PNH Patient Treated With Coversin31 March 2016
Opthea Completes Patient Enrolment for OPT-302 Phase 1 Dose Escalation Trial in Patients With Wet AMD31 March 2016
aTyr Pharma Announces Encouraging Phase 1b/2 Results for Resolaris™ in its First Rare Myopathy TrialNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports